Chronic neuroleptic effects on dopamine neuron activity: a model for predicting therapeutic efficacy and side effects?
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects*; D013681:Tegmentum Mesencephali / Q000187:drug effects*; D013997:Time Factors
D014150:Antipsychotic Agents; D004298:Dopamine